Glow-in-the-Dark dye could help doctors find hidden prostate cancer

NCT ID NCT06906471

Recruiting now Diagnosis Sponsor: Antelope Surgical Solutions, Inc Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This early trial tests a fluorescent dye called AS1986NS that aims to make prostate cancer cells glow during a biopsy. Ten men with suspected prostate cancer will receive a tiny dose of the dye before their standard biopsy. The main goal is to check that the dye is safe, not yet to prove it improves cancer detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AS1986NS (a fluorescent dye)
What this could lead to: If it works, this could help doctors see prostate cancer more clearly during biopsy, potentially reducing missed cancers.
What could go wrong: This is a very early, tiny study (10 people) focused on safety, not on proving the dye improves detection. It may not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FLUORESCENCE IMAGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FLUORESCENCE IMAGING PROSTATE CANCER PROSTATE CANCER (ADENOCARCINOMA)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

HCA Florida Kendall Hospital
RECRUITING

Miami, Florida, 33175, United States
Icahn School of Medicine at Mount Sinai (ISMMS)
NOT_YET_RECRUITING

New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.